Evolving Role of JAK Inhibitors in Myelofibrosis and Beyond
EP. 1: A Review of Myeloproliferative Diseases
December 24th 2019
EP. 2: The Use of Ruxolitinib in MPN
December 24th 2019
EP. 3: Key Data for the Use of Fedratinib in MF
December 24th 2019
EP. 4: Upcoming Therapies for Use in MPN
December 24th 2019
EP. 5: Adverse Events Seen with JAK Inhibition in MPN
December 24th 2019
EP. 6: Treatment After Ruxolitinib Failure in MPN
December 24th 2019
EP. 7: Management of Toxicities in Patients Treated for MPN
December 24th 2019
